{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:19:48Z","timestamp":1793801988865,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polypharmacy (concomitant prescription of \u2265\u20095 medications) affects a third of older people, and evidence suggests an association with sarcopenia (loss of skeletal muscle mass\/quality, muscle strength, and\/or physical performance). As such, deprescribing has been recommended in routine management of sarcopenia, however it\u2019s unknown whether deprescribing is beneficial. This systematic review aimed to understand effects of deprescribing on sarcopenia parameters in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medline, Embase, CINAHL, Web of Science, and the Cochrane Library databases were searched up to July 2023. All studies reporting effects of deprescribing interventions on sarcopenia parameters (primary outcomes) or nutritional intake (secondary outcomes) among older adults were included. Findings were summarised narratively, and study quality was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 4860 articles were identified and six were included (mean age range 67\u201387 years). Studies were heterogeneous in design, settings, follow-up periods, and outcomes. Deprescribing had no effect on skeletal muscle mass (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092). Positive effects were shown on handgrip strength with two studies reporting improvements following antihypertensive or benzodiazepines discontinuation and one showing no change between admission and discharge with general deprescribing. Outcomes of deprescribing on physical function outcomes varied based on the measures used. For example, one study showed no changes in timed up and go, Whereas effects on gait speed was contradictory in two studies, with preservation and deterioration reported. Two studies reported improvement between baseline and follow up in balance scores measured part of the Short physical performance battery or using the Short Berg\u2019s Balance Scale among those who discontinued antihypertensive and\/or benzodiazepines. Two studies reported improvements in nutritional outcomes following deprescribing at hospital discharge, whereas two other studies reported no change or increase in weight loss.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is limited research about the impact of deprescribing on sarcopenia parameters. This systematic review found no significant changes in muscle mass but there is some evidence in improvements in strength, physical performance, and nutritional status with deprescribing. The multidisciplinary implementation of nutrition and exercise therapies, as well as medication management to modify polypharmacy, may further promote improvement in sarcopenia. However, more high-quality research is needed to understand the effects of deprescribing on sarcopenia parameters among older people including those with confirmed diagnosis of sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration<\/jats:title>\n                    <jats:p>The review was registered on the international prospective register of systematic reviews (PROSPERO, CRD42023417997).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-025-05819-7","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:47:16Z","timestamp":1741330036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The evidence and impact of deprescribing on sarcopenia parameters: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Kinda","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E. R.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Radcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Lundby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Prokopidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"1","key":"5819_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"1","key":"5819_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2049-3258-72-45","volume":"72","author":"C Beaudart","year":"2014","unstructured":"Beaudart C, et al. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72(1):45.","journal-title":"Arch Public Health"},{"issue":"4","key":"5819_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"issue":"6","key":"5819_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2217\/ahe.10.78","volume":"6","author":"D Gnjidic","year":"2010","unstructured":"Gnjidic D, Hilmer SN. Use of potentially inappropriate medications in the care of frail older people. Aging Health. 2010;6(6):705\u201316.","journal-title":"Aging Health"},{"key":"5819_CR5","doi-asserted-by":"crossref","unstructured":"Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2013. 2.","DOI":"10.1002\/14651858.CD008986.pub2"},{"issue":"3","key":"5819_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2125.2011.04010.x","volume":"72","author":"C-B Chang","year":"2011","unstructured":"Chang C-B, et al. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol. 2011;72(3):482\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"5819_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, et al. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21(2):181\u20137.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"5819_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00223-018-0478-1","volume":"104","author":"R Pinedo-Villanueva","year":"2019","unstructured":"Pinedo-Villanueva R, et al. Health care costs associated with muscle weakness: A UK Population-Based estimate. Calcif Tissue Int. 2019;104(2):137\u201344.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"5819_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40520-021-01951-7","volume":"34","author":"LV Fernandes","year":"2022","unstructured":"Fernandes LV, et al. Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review. Aging Clin Exp Res. 2022;34(3):505\u201314.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"5819_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/ggi.14770","volume":"24","author":"M Kuzuya","year":"2024","unstructured":"Kuzuya M. Drug-related sarcopenia as a secondary sarcopenia. Geriatr Gerontol Int. 2024;24(2):195\u2013203.","journal-title":"Geriatr Gerontol Int"},{"issue":"3","key":"5819_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/jcsm.12177","volume":"8","author":"JA Pasco","year":"2017","unstructured":"Pasco JA, et al. Musculoskeletal decline and mortality: prospective data from the Geelong osteoporosis study. J Cachexia Sarcopenia Muscle. 2017;8(3):482\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5819_CR12","doi-asserted-by":"crossref","unstructured":"Love B.L., Mitchell E.M., Norris L.B. Association between reduced handgrip strength and commonly prescribed medications. MedRxiv. 2020. 2020.01.15.20017087.","DOI":"10.1101\/2020.01.15.20017087"},{"issue":"10","key":"5819_CR13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/pds.1797","volume":"18","author":"RM Boudreau","year":"2009","unstructured":"Boudreau RM, et al. Central nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study. Pharmacoepidemiol Drug Saf. 2009;18(10):916\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"5819_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s41999-021-00511-6","volume":"12","author":"MK Sandvik","year":"2021","unstructured":"Sandvik MK, et al. Association between psychotropic drug use and handgrip strength in older hospitalized patients. Eur Geriatr Med. 2021;12(6):1213\u201320.","journal-title":"Eur Geriatr Med"},{"issue":"3","key":"5819_CR15","first-page":"36","volume":"2","author":"M Mathews","year":"2005","unstructured":"Mathews M, et al. Antipsychotic-induced movement disorders: evaluation and treatment. Psychiatry (Edgmont). 2005;2(3):36\u201341.","journal-title":"Psychiatry (Edgmont)"},{"issue":"10","key":"5819_CR16","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.2522\/ptj.20090251","volume":"90","author":"SL Di Stasi","year":"2010","unstructured":"Di Stasi SL, et al. Effects of Statins on skeletal muscle: a perspective for physical therapists. Phys Ther. 2010;90(10):1530\u201342.","journal-title":"Phys Ther"},{"issue":"1","key":"5819_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008;197(1):1\u201310.","journal-title":"J Endocrinol"},{"issue":"4","key":"5819_CR18","first-page":"476","volume":"35","author":"FdADM Junior","year":"2022","unstructured":"Junior FdADM, et al. Use of diuretics is associated with higher risk of sarcopenia in older adults with hypertension. Int J Cardiovasc Sci. 2022;35(4):476\u201385.","journal-title":"Int J Cardiovasc Sci"},{"issue":"10","key":"5819_CR19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent E, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148\u201361.","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"5819_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jamda.2020.05.065","volume":"22","author":"C Stewart","year":"2021","unstructured":"Stewart C, et al. Anticholinergic burden measures predict older People\u2019s physical function and quality of life: A systematic review. J Am Med Dir Assoc. 2021;22(1):56\u201364.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"5819_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/nu8020069","volume":"8","author":"F Landi","year":"2016","unstructured":"Landi F, et al. Anorexia of aging: risk factors, consequences, and potential treatments. Nutrients. 2016;8(2):69.","journal-title":"Nutrients"},{"issue":"1","key":"5819_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40266-013-0134-4","volume":"31","author":"G Onder","year":"2014","unstructured":"Onder G, et al. Recommendations to prescribe in complex older adults: results of the criteria to assess appropriate medication use among elderly complex patients (CRIME) project. Drugs Aging. 2014;31(1):33\u201345.","journal-title":"Drugs Aging"},{"issue":"1","key":"5819_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1515\/med-2021-0364","volume":"16","author":"X Wang","year":"2021","unstructured":"Wang X, Wu M. Research progress of gut microbiota and frailty syndrome. Open Med (Wars). 2021;16(1):1525\u201336.","journal-title":"Open Med (Wars)"},{"key":"5819_CR24","doi-asserted-by":"publisher","first-page":"233372142092039","DOI":"10.1177\/2333721420920398","volume":"6","author":"L Dismore","year":"2020","unstructured":"Dismore L, et al. Study of the older adults\u2019 motivators and barriers engaging in a nutrition and resistance exercise intervention for sarcopenia: an embedded qualitative project in the milkman pilot study. Gerontol Geriatric Med. 2020;6:2333721420920398.","journal-title":"Gerontol Geriatric Med"},{"key":"5819_CR25","doi-asserted-by":"publisher","first-page":"101940","DOI":"10.1016\/j.arr.2023.101940","volume":"88","author":"M Izquierdo","year":"2023","unstructured":"Izquierdo M, Fiatarone M, Singh. Promoting resilience in the face of ageing and disease: the central role of exercise and physical activity. Ageing Res Rev. 2023;88:101940.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"5819_CR26","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/nu15092163","volume":"15","author":"Y Yoshimura","year":"2023","unstructured":"Yoshimura Y, AO - Yoshimura Y. Prevention and treatment of sarcopenia: multidisciplinary approaches in clinical practice. Nutrients. 2023;15(9):2163.","journal-title":"Nutrients"},{"issue":"1","key":"5819_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12877-022-03408-6","volume":"22","author":"LK O\u2019Donnell","year":"2022","unstructured":"O\u2019Donnell LK, Ibrahim K. Polypharmacy and deprescribing: challenging the old and embracing the new. BMC Geriatr. 2022;22(1):734.","journal-title":"BMC Geriatr"},{"key":"5819_CR28","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"issue":"1","key":"5819_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","volume":"21","author":"K Ibrahim","year":"2021","unstructured":"Ibrahim K, et al. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21(1):258.","journal-title":"BMC Geriatr"},{"issue":"4","key":"5819_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","volume":"40","author":"HC Roberts","year":"2011","unstructured":"Roberts HC, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423\u20139.","journal-title":"Age Ageing"},{"issue":"1","key":"5819_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12891-021-04524-x","volume":"22","author":"S Sawada","year":"2021","unstructured":"Sawada S, et al. The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants. BMC Musculoskelet Disord. 2021;22(1):639.","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"5819_CR32","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s12603-018-1104-7","volume":"22","author":"JP MacEwan","year":"2018","unstructured":"MacEwan JP, et al. Measuring sarcopenia severity in older adults and the value of effective interventions. J Nutr Health Aging. 2018;22(10):1253\u20138.","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"5819_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-01642-4","volume":"20","author":"S Phu","year":"2020","unstructured":"Phu S, et al. The diagnostic value of the short physical performance battery for sarcopenia. BMC Geriatr. 2020;20(1):1\u20137.","journal-title":"BMC Geriatr"},{"issue":"Suppl 1","key":"5819_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ggi.12197","volume":"14","author":"S Ishii","year":"2014","unstructured":"Ishii S, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014;14(Suppl 1):93\u2013101.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"5819_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12877-022-03231-z","volume":"22","author":"S Salini","year":"2022","unstructured":"Salini S, et al. Self-reported difficulty in walking 400 meters: the red flag for probable sarcopenia. BMC Geriatr. 2022;22(1):530.","journal-title":"BMC Geriatr"},{"issue":"6","key":"5819_CR36","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, et al. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J Appl Physiol (1985). 2004;97(6):2333\u20138.","journal-title":"J Appl Physiol (1985)"},{"key":"5819_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clnesp.2022.03.007","volume":"49","author":"WE Kok","year":"2022","unstructured":"Kok WE, et al. The association between polypharmacy and malnutrition(risk) in older people: A systematic review. Clin Nutr ESPEN. 2022;49:163\u201371.","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"5819_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"5819_CR39","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","volume":"368","author":"M Campbell","year":"2020","unstructured":"Campbell M, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890.","journal-title":"BMJ"},{"key":"5819_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.archger.2021.104472","volume":"96","author":"E Idil","year":"2021","unstructured":"Idil E, et al. Rationally decreasing the number of drugs seems to be a useful therapeutic approach in older adults: 6-month follow-up study. Arch Gerontol Geriatr. 2021;96:6.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"5819_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2318-14-121","volume":"14","author":"J Nurminen","year":"2014","unstructured":"Nurminen J, et al. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, Zopiclone or Zolpidem as hypnotics. BMC Geriatr. 2014;14(1):121.","journal-title":"BMC Geriatr"},{"issue":"10","key":"5819_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/03000605221130716","volume":"50","author":"S Hasegawa","year":"2022","unstructured":"Hasegawa S, et al. Effects of discontinuation of antihypertensive drugs on frailty syndrome in outpatients: a 1-year prospectively designed retrospective chart-review pilot study. J Int Med Res. 2022;50(10):10.","journal-title":"J Int Med Res"},{"key":"5819_CR43","doi-asserted-by":"crossref","unstructured":"Matsumoto A et al. Deprescribing leads to improved energy intake among hospitalized older sarcopenic adults with polypharmacy after stroke. Nutrients. 2022; 14(3).","DOI":"10.3390\/nu14030443"},{"key":"5819_CR44","doi-asserted-by":"publisher","first-page":"112040","DOI":"10.1016\/j.nut.2023.112040","volume":"111","author":"E K","year":"2023","unstructured":"K. E, et al. Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke. Nutrition. 2023;111:112040.","journal-title":"Nutrition"},{"issue":"4","key":"5819_CR45","doi-asserted-by":"publisher","first-page":"p1","DOI":"10.1093\/ageing\/afac092","volume":"51","author":"EE Roughead","year":"2022","unstructured":"Roughead EE, et al. Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the remindar trial). Age Ageing. 2022;51(4):p1\u20139.","journal-title":"Age Ageing"},{"key":"5819_CR46","doi-asserted-by":"publisher","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201381. https:\/\/doi.org\/10.1111\/jgs.18372. Epub 2023 May 4. PMID: 37139824.","DOI":"10.1111\/jgs.18372"},{"key":"5819_CR47","doi-asserted-by":"crossref","unstructured":"Rankin A et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018; 9.","DOI":"10.1002\/14651858.CD008165.pub4"},{"issue":"12","key":"5819_CR48","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2165\/0002512-200825120-00004","volume":"25","author":"S Iyer","year":"2008","unstructured":"Iyer S, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021\u201331.","journal-title":"Drugs Aging"},{"issue":"3","key":"5819_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","volume":"20","author":"CH Kua","year":"2019","unstructured":"Kua CH, Mak VSL, Lee SWH. Health outcomes of deprescribing interventions among older residents in nursing homes: A systematic review and Meta-analysis. J Am Med Dir Assoc. 2019;20(3):362\u201372.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"5819_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12877-020-01634-4","volume":"20","author":"H Almutairi","year":"2020","unstructured":"Almutairi H, et al. Optimisation of medications used in residential aged care facilities: a systematic review and meta-analysis of randomised controlled trials. BMC Geriatr. 2020;20(1):236.","journal-title":"BMC Geriatr"},{"issue":"675","key":"5819_CR51","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.3399\/bjgp18X699041","volume":"68","author":"SL Thio","year":"2018","unstructured":"Thio SL, et al. Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials. Br J Gen Pract. 2018;68(675):e663\u201372.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"5819_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12877-019-1031-4","volume":"19","author":"J Ulley","year":"2019","unstructured":"Ulley J, et al. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019;19(1):15.","journal-title":"BMC Geriatr"},{"issue":"4","key":"5819_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40266-018-0536-4","volume":"35","author":"J Thillainadesan","year":"2018","unstructured":"Thillainadesan J, et al. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: A systematic review of randomised trials. Drugs Aging. 2018;35(4):303\u201319.","journal-title":"Drugs Aging"},{"issue":"10","key":"5819_CR54","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/jgs.16697","volume":"68","author":"CE Aubert","year":"2020","unstructured":"Aubert CE, et al. Outcome measures for interventions to reduce inappropriate chronic drugs: A narrative review. J Am Geriatr Soc. 2020;68(10):2390\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"5819_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cger.2016.08.002","volume":"33","author":"RJ Dhillon","year":"2017","unstructured":"Dhillon RJ, Hasni S. Pathogenesis and management of sarcopenia. Clin Geriatr Med. 2017;33(1):17\u201326.","journal-title":"Clin Geriatr Med"},{"key":"5819_CR56","doi-asserted-by":"publisher","first-page":"112040","DOI":"10.1016\/j.nut.2023.112040","volume":"111","author":"E Kose","year":"2023","unstructured":"Kose E, Matsumoto A, Yoshimura Y. Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke. Nutrition. 2023;111:112040.","journal-title":"Nutrition"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-05819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-05819-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-05819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:27:59Z","timestamp":1741332479000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-05819-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5819"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-05819-7","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a systematic review of published studies, and no additional consent is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}